The prevalence of severe asymptomatic carotid stenosis in the general population is low (0% to 3.1%), which is relevant for evaluating the cost-effectiveness of screening programs.
Cautions against broad screening due to low yield; leaves open targeted cost-effectiveness analyses in higher-risk groups.
The prevalence of severe asymptomatic carotid stenosis in the general population ranges from 0% to 3.1%, which is useful information in the discussion on the cost-effectiveness of screening.
No takes yet. Share an insight, caveat, or question.
Weerd et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: